Exploring the Evidence: Treatment Considerations for MS in a Crowded Landscape

Released On
December 1, 2021

Expires On
December 1, 2022

Media Type
Internet

Completion Time
60 minutes

Specialty
Neurology, Pharmacy, Primary Care

Topic(s)
Multiple Sclerosis

Scroll to the Bottom of this Information to Begin this Course

This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education.

This activity is supported by an independent educational grant from Biogen.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Nurses — 1.0 Contact Hours
  • Pharmacists - 1.0 Contact Hours

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity is designed to meet the educational needs of neurology physicians, nurse practitioners, PAs, pharmacists, and other healthcare professionals involved in the care of patients living with MS.

Program Overview

This timely live webinar provides an overview of the efficacy, safety, side effects, and immune system impact of MS disease-modifying therapies. Our distinguished faculty also discuss sequencing considerations, including vaccines, that can impact the choice of MS therapy for individuals living with MS.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Examine information about the efficacy, safety, side effects, and immune system impact for treatment selection
  • Discuss sequencing considerations, including vaccines, that can impact the choice for the most appropriate MS therapy

 

Faculty

Robert K. Shin, MD, FANA, FAAN

Professor, Department of Neurology
MedStar Georgetown University Hospital

Lori Mayer, DNP, NP-C, APRN, MSN, RN, MSCN

Assistant Medical Director
Elligo Research

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designations

Physicians
The CMSC designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
The CMSC designates this activity for a maximum of 1.0 contact hours of nursing continuing professional development (NCPD) (1.0 in the area of pharmacology).

Pharmacists
This knowledge-based activity, JA4008165-9999-21-017-H01-P, qualifies for 1.0 contact hours (.10 CEUs) of continuing pharmacy education credit.

Disclosures of Conflicts of Interest

It is the policy of the Consortium of Multiple Sclerosis Centers (CMSC) to ensure balance, independence, objectivity, and scientific rigor in all educational activities. All faculty, planning committee members, content reviewers, and staff participating in this activity have disclosed any relevant financial relationships they or their significant other have had within the previous 12 months with manufacturers of any commercial products/devices and/or providers of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. All presentations were reviewed by an independent clinician with no relevant financial relationships for the purpose of resolution of any identified conflict of interest and a determination of evidence-base and fair balance.

Robert K. Shin, MD, FANA, FAAN

  • Consulting Fees: Biogen, Bristol Myers Squibb, EMD Serono, Mallinckrodt, Novartis Pharmaceuticals Corporation, Sanofi Genzyme
  • Speakers Bureau: Biogen, Bristol Myers Squibb, EMD Serono, Mallinckrodt, Novartis Pharmaceuticals Corporation, Sanofi Genzyme

 

Lori Mayer, DNP, NP-C, APRN, MSN, RN, MSCN

  • Consulting Fees: Bristol Myers Squibb, TG Therapeutics
  • Speakers Bureau: Bristol Myers Squibb

 

Activity Staff Disclosures

June Halper, MSN, APN-C, MSCN, FAAN, and Laurie Scudder, DNP, NP, served as planners and reviewers and have disclosed no relevant financial relationships.

All other planners, reviewers, staff, or other members of the Continuing Professional Education Committee at the Consortium of Multiple Sclerosis Centers who control content have disclosed no relevant financial relationships.

The planners, reviewers, editors, staff, CME committee, or other members at Catamount Medical Education who control content have disclosed no relevant financial relationships.

Instructions for Participation and Credit

This activity is an online enduring material. There are no fees for participating and receiving credit for this activity. Successful completion is achieved by reviewing the CE information, completing the pre-test, viewing the video, studying the educational activity and completing the post-test and the evaluation form. Upon completion of the evaluation, your certificate will be made available immediately. Click on "View Certificate" and print the certificate for your records.

The estimated time to complete the activity is 60 minutes.

This activity was originally released on November 30, 2021, and is eligible for credit through November 30, 2022.

Course Viewing Requirements

This site is best viewed with an HTML5 compatible browser. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser.

Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, and Real Networks Real One Player.

Our Policy on Privacy

The Consortium of Multiple Sclerosis Centers and Catamount Medical Education, LLC, respect your privacy. All personal information that is provided to Catamount Medical Education, LLC, is protected and will not be sold to a third party for commercial purposes. All personally identifiable information contained in the Catamount Medical Education, LLC, registration databases is treated as confidential and will be used only for the purposes stated in this policy, except where required by law. Catamount Medical Education, LLC, maintains user databases that contain mailing and user profile information as well as a record of the CE activities viewed and the post-test and evaluation results for CE credit. This information is provided to activity collaborators for the purposes of CE recordkeeping. By participating in this activity, you agree that Catamount Medical Education, LLC, has full permission to provide this information.

Catamount Medical Education, LLC, safeguards against the loss, misuse, or alteration of information that we have collected in this activity.

Disclosure of Unlabeled Use

CMSC and Catamount Medical Education require CE faculty (speakers) to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information

For questions about this activity, please contact Catamount Medical Education at info@catmeded.com.